WallStSmart
PBM

Psyence Biomedical Ltd. Common Shares

NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY

$3.61
+6.18% today

Updated 2026-10-29

Market cap
$15.89M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-12.56
Dividend yield
—
52W range
$2 – $21
Volume
0.1M

Psyence Biomedical Ltd. Common Shares (PBM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+3.1%
Most recent quarter

When is the next earnings report?

Reporting date
June 30, 2026
Consensus EPS estimate
—
Fiscal period ending
2026-06-30

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-46.6%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-46.6%
2025-11-20
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-20$-0.51—$2.79$1.49-46.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-06-30—————
2025-09-30$0.00$-0.51———
2025-03-31$0.00$-99.97———
2024-12-31$0.00$4.06———
2024-09-30—$0.04———
2023-09-30—$-0.53———
2023-06-30—$-0.05———
2023-03-31—$-0.01———
2022-12-31—$0.05———
2022-09-30—$0.03———
2022-06-30—$0.07———
2022-03-31—$0.25———

Frequently asked questions

When does Psyence Biomedical Ltd. Common Shares report next earnings?

Psyence Biomedical Ltd. Common Shares (PBM) is scheduled to report earnings on June 30, 2026.

Has Psyence Biomedical Ltd. Common Shares beaten earnings estimates?

Psyence Biomedical Ltd. Common Shares has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does PBM stock react to earnings?

PBM has moved an average of -46.6% the day after earnings over its last 1 reports, finishing higher after 0 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.